TRIM21 was originally implicated in innate immunity, autoimmune responses, and cancer (52–54); however, recent studies have suggested a role in cancer metabolism through ubiquitination and degradation of enzymes and signaling regulators (55–59). Here, TRIM21 is linked to cancer.